Goldman Sachs’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$41.2M Buy
560,669
+55,322
+11% +$4.06M 0.01% 1256
2025
Q1
$57.7M Sell
505,347
-120,899
-19% -$13.8M 0.01% 981
2024
Q4
$31.6M Buy
626,246
+153,225
+32% +$7.72M 0.01% 1422
2024
Q3
$21.9M Sell
473,021
-5,553
-1% -$257K ﹤0.01% 1669
2024
Q2
$15.5M Buy
478,574
+43,852
+10% +$1.42M ﹤0.01% 1757
2024
Q1
$11M Sell
434,722
-98,038
-18% -$2.47M ﹤0.01% 1980
2023
Q4
$17.3M Buy
532,760
+124,185
+30% +$4.03M ﹤0.01% 1674
2023
Q3
$11.1M Buy
408,575
+45,308
+12% +$1.23M ﹤0.01% 1909
2023
Q2
$8.08M Sell
363,267
-40,164
-10% -$894K ﹤0.01% 2208
2023
Q1
$8.74M Sell
403,431
-70,770
-15% -$1.53M ﹤0.01% 2115
2022
Q4
$9.63M Buy
474,201
+52,208
+12% +$1.06M ﹤0.01% 2159
2022
Q3
$10.8M Buy
421,993
+113,353
+37% +$2.91M ﹤0.01% 2063
2022
Q2
$7.34M Sell
308,640
-39,946
-11% -$950K ﹤0.01% 2367
2022
Q1
$7.85M Sell
348,586
-2,760
-0.8% -$62.2K ﹤0.01% 2444
2021
Q4
$6.96M Sell
351,346
-207,637
-37% -$4.11M ﹤0.01% 2554
2021
Q3
$11M Buy
558,983
+165,748
+42% +$3.26M ﹤0.01% 2186
2021
Q2
$8.65M Sell
393,235
-90,781
-19% -$2M ﹤0.01% 2361
2021
Q1
$11.5M Sell
484,016
-48,457
-9% -$1.15M ﹤0.01% 2108
2020
Q4
$13.9M Buy
532,473
+55,759
+12% +$1.46M ﹤0.01% 1826
2020
Q3
$8.3M Sell
476,714
-483,997
-50% -$8.42M ﹤0.01% 2067
2020
Q2
$16.2M Buy
960,711
+98,581
+11% +$1.66M ﹤0.01% 1610
2020
Q1
$10.3M Buy
862,130
+398,019
+86% +$4.73M ﹤0.01% 1787
2019
Q4
$5.62M Buy
464,111
+181,786
+64% +$2.2M ﹤0.01% 2355
2019
Q3
$3.99M Buy
282,325
+68,355
+32% +$966K ﹤0.01% 2462
2019
Q2
$2.39M Sell
213,970
-335,867
-61% -$3.75M ﹤0.01% 2713
2019
Q1
$6.46M Sell
549,837
-29,794
-5% -$350K ﹤0.01% 2276
2018
Q4
$7.74M Buy
579,631
+5,231
+0.9% +$69.9K ﹤0.01% 2059
2018
Q3
$8.05M Sell
574,400
-264,977
-32% -$3.71M ﹤0.01% 2169
2018
Q2
$13.2M Buy
839,377
+272,775
+48% +$4.29M ﹤0.01% 1863
2018
Q1
$9.32M Sell
566,602
-110,630
-16% -$1.82M ﹤0.01% 1948
2017
Q4
$12.2M Buy
677,232
+45,669
+7% +$825K ﹤0.01% 1808
2017
Q3
$12.2M Buy
631,563
+358,748
+131% +$6.92M ﹤0.01% 1870
2017
Q2
$3.22M Buy
272,815
+57,523
+27% +$679K ﹤0.01% 2518
2017
Q1
$2.36M Buy
215,292
+83,026
+63% +$910K ﹤0.01% 2628
2016
Q4
$960K Buy
132,266
+7,473
+6% +$54.2K ﹤0.01% 3120
2016
Q3
$811K Buy
124,793
+64,074
+106% +$416K ﹤0.01% 3174
2016
Q2
$332K Buy
60,719
+9,765
+19% +$53.4K ﹤0.01% 3575
2016
Q1
$238K Buy
50,954
+1,777
+4% +$8.3K ﹤0.01% 3673
2015
Q4
$244K Buy
49,177
+21,023
+75% +$104K ﹤0.01% 3624
2015
Q3
$106K Sell
28,154
-6,915
-20% -$26K ﹤0.01% 4142
2015
Q2
$211K Buy
+35,069
New +$211K ﹤0.01% 3975
2014
Q3
Sell
-163,159
Closed -$457K 4518
2014
Q2
$457K Buy
163,159
+135,442
+489% +$379K ﹤0.01% 3409
2014
Q1
$121K Buy
27,717
+5,942
+27% +$25.9K ﹤0.01% 4107
2013
Q4
$70K Buy
21,775
+6,425
+42% +$20.7K ﹤0.01% 4139
2013
Q3
$24K Buy
+15,350
New +$24K ﹤0.01% 4142